AMEX:TOVX
Theriva Biologics, Inc.
- Stock
Last Close
0.27
26/07 19:58
Market Cap
4.72M
Beta: 1.59
Volume Today
48.14K
Avg: 39.97K
PE Ratio
−0.45
PFCF: −0.45
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | ||||||||||||
cost of revenue | 240K - | 201K 16.25% | 87K 56.72% | 268K 208.05% | 135K 49.63% | |||||||
gross profit | -240K - | -201K 16.25% | -87K 56.72% | -268K 208.05% | -135K 49.63% | |||||||
selling and marketing expenses | 525K - | |||||||||||
general and administrative expenses | 5.73M - | 4.58M 20.03% | 5.03M 9.80% | 6.47M 28.73% | 9.86M 52.27% | 7.12M 27.77% | ||||||
selling general and administrative expenses | 5.83M - | 6.01M 3.10% | 8.07M 34.28% | 10.14M 25.63% | 7.47M 26.38% | 5.73M 23.30% | 4.58M 20.03% | 5.03M 9.80% | 6.47M 28.73% | 9.86M 52.27% | 7.64M 22.45% | |
research and development expenses | 6.51M - | 14.49M 122.67% | 32.91M 127.11% | 29.11M 11.54% | 18.78M 35.47% | 11.84M 36.95% | 11.08M 6.43% | 5.13M 53.70% | 7.80M 52.02% | 11.72M 50.29% | 14.31M 22.08% | |
other expenses | ||||||||||||
cost and expenses | 12.34M - | 20.50M 66.16% | 40.98M 99.88% | 39.25M 4.22% | 26.25M 33.12% | 17.57M 33.07% | 15.66M 10.86% | 10.16M 35.13% | 14.27M 40.49% | 21.58M 51.19% | 22.09M 2.36% | |
operating expenses | 12.34M - | 20.50M 66.16% | 40.98M 99.88% | 39.25M 4.22% | 26.25M 33.12% | 17.57M 33.07% | 15.66M 10.86% | 10.16M 35.13% | 14.27M 40.49% | 21.58M 51.19% | 21.96M 1.74% | |
interest expense | -430K - | |||||||||||
ebitda | -12.28M - | -21.20M 72.56% | -37.10M 75.01% | -50.51M 36.15% | -36.74M 27.25% | -21.38M 41.81% | -15.42M 27.87% | -9.96M 35.43% | -14.27M 43.33% | -21.45M 50.31% | -21.96M 2.34% | |
operating income | -12.34M - | -20.50M 66.16% | -40.98M 99.88% | -39.25M 4.22% | -26.25M 33.12% | -17.57M 33.07% | -15.66M 10.86% | -10.16M 35.13% | -14.27M 40.49% | -21.58M 51.19% | -22.09M 2.36% | |
depreciation and amortization | 43K - | 20K 53.49% | 72K 260% | 157K 118.06% | 245K 56.05% | 272K 11.02% | 240K 11.76% | 201K 16.25% | 87K 56.72% | 126K 44.83% | 135K 7.14% | |
total other income expenses net | -12K - | 715K 6,058.33% | -3.81M 633.01% | 11.41M 399.45% | 10.74M 5.91% | 4.08M 61.98% | 283K 93.07% | 44K 84.45% | 6K 86.36% | 471K 7,750% | 2.10M 346.28% | |
income before tax | -12.32M - | -19.78M 60.61% | -44.78M 126.37% | -27.80M 37.92% | -15.49M 44.28% | -13.42M 13.37% | -15.38M 14.60% | -10.12M 34.23% | -14.27M 41.04% | -21.11M 47.95% | -19.99M 5.31% | |
income tax expense | -22K - | -718K 3,163.64% | 2.76M 483.98% | -12.00M 535.15% | -11.08M 7.67% | -4.20M 62.05% | -360K 91.44% | -117K 67.50% | -94K 19.66% | -1.43M 1,415.96% | -1.64M 15.09% | |
net income | -12.32M - | -19.78M 60.62% | -43.74M 121.07% | -27.25M 37.68% | -15.17M 44.33% | -13.37M 11.91% | -15.02M 12.37% | -10.00M 33.43% | -14.17M 41.75% | -19.68M 38.88% | -18.35M 6.79% | |
weighted average shs out | 130.48K - | 176.98K 35.64% | 230.58K 30.29% | 269.40K 16.83% | 355.33K 31.90% | 623.24K 75.40% | 1.64M 163.75% | 1.90M 15.65% | 12.19M 541.06% | 15.33M 25.76% | 16.11M 5.09% | |
weighted average shs out dil | 130.48K - | 176.98K 35.64% | 230.58K 30.29% | 269.40K 16.83% | 355.33K 31.90% | 623.24K 75.40% | 1.64M 163.75% | 1.90M 15.65% | 12.19M 541.06% | 15.33M 25.76% | 16.11M 5.09% | |
eps | -94.40 - | -111.78 18.41% | -189.68 69.69% | -101.17 46.66% | -42.70 57.79% | -21.45 49.77% | -9.14 57.39% | -5.26 42.45% | -1.16 77.95% | -1.28 10.34% | -1.14 10.94% | |
epsdiluted | -94.40 - | -111.78 18.41% | -189.68 69.69% | -101.17 46.66% | -42.70 57.79% | -21.45 49.77% | -9.14 57.39% | -5.26 42.45% | -1.16 77.95% | -1.28 10.34% | -1.14 10.94% |
All numbers in USD (except ratios and percentages)